Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Cell Death & Disease|September 20, 2019
Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding proteinJung S Byun, Samson Park, Dae Ik Yi, et al.
Communications Biology|February 2, 2021
Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survivalSandeep K Singhal, Jung S Byun, Samson Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2025
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 studyC Gratzke, M Özgüroğlu, A Peer, et al.
European Journal of Gastroenterology & Hepatology|October 10, 2018
Prognosis of patients with gastric variceal bleeding after endoscopic variceal obturation according to the type of varicesHan A Lee, Jung M Chang, Hyun G Goh, et al.
JCI Insight|May 31, 2022
Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on raceSandeep K Singhal, Jung S Byun, Tingfen Yan, et al.
Journal of Viral Hepatitis|February 12, 2016
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virusS H Ahn, Y S Lim, K S Lee, et al.
Journal of the National Cancer Institute. Monographs|August 5, 2024
Reporting tumor genomic test results to SEER registries via linkagesValentina I Petkov, Jung S Byun, Kevin C Ward, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Schizophrenia Research|August 23, 2012
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessionsBrandon Abbs, Rashmin M Achalia, Adegoke O Adelufosi, et al.
Pageof 19